S. 2760: Reducing Hereditary Cancer Act of 2025
A Senate bill (S.) in the 119th U.S. Congress.
Overview
| Congress | 119th U.S. Congress (2025–2026) |
|---|---|
| Type | Senate bill (S.) |
| Originating chamber | Senate |
| Introduced | 2025-09-10 |
| Sponsor | Sen. Murkowski, Lisa [R-AK] |
| Policy area | Health |
| Cosponsors | 1 |
| Latest action | 2025-09-10 — Read twice and referred to the Committee on Finance. |
| Last updated | 2025-12-05 |
Summary
Official summary (Introduced in Senate, 2025-09-10):
Reducing Hereditary Cancer Act of 2025
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Cosponsors (1)
| Name | Party / state |
|---|---|
| Elissa Slotkin | D MI (original cosponsor) 2025-09-10 |
Full text & official record
The official bill text, section-by-section summary, amendments, committee reports, and the complete legislative timeline for S. 2760 are published by Congress on congress.gov.
View S. 2760 on congress.gov →
Frequently asked questions
What is S. 2760?
S. 2760 is a Senate bill (S.) introduced in the 119th U.S. Congress, originating in the Senate. Official title: Reducing Hereditary Cancer Act of 2025.
Where can I read the full bill text?
The full text, cosponsors, amendments, and legislative status for S. 2760 are available on congress.gov.
Bill data: congress.gov API (official congressional records).